Will
NCCN - (National Cancer Care Cost Network) &
ESMO ( Evaluation of standards in Medical Oncology) will discuss such studies.
Congratulations to Russian authors to brining this piece of work. Certainly a practice changing...
Encourage EVERYONE - at all levels of training - to check out The First International Summit on Interventional Pharmacoeconomics @ https://t.co/kyXggWoSM6
An incredible speaker lineup and a pressing topic. This one is not to be missed.
Approach to Gastric & GEJ Cancer during COVID19 Systemic treatment of gastroesophageal cancer during SARS-CoV2 Ghosh J, Ganguly S, Biswas B, Dabkara D, Srivastava P, Patel A, Batra A, Mehta P, - Indian J Med Paediatr Oncol #SACCC#GICancer#GastricCancer https://t.co/NaK6bL3C0v
Breast cancer treatment during the COVID-19 pandemic Batra A, Mehta P, Patel A, Bhethanabhotla S, Biswas B, Pramanik R, Das CK, - Indian J Med Paediatr Oncology #SACCC#COVID19#COVID19&Cancer #BreastCancer https://t.co/QXX5y2NSQu
Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets with Legendary mentor and philosopher Proffeser Ian F. Tannock @ian_tannock#SACCC#UroOncology#ProstateCancer#CRPC https://t.co/sztbWgMIOI…